Management of insulinoma in a dog with subcutaneous diluted glucagon and a continuous glucose monitoring system

Glucagon has been shown effective for the treatment of insulinoma-associated hypoglycemia. However, its use limited to preoperative supportive care and emergency hypoglycemic crisis because need constant intravenous infusion administration. Here, we report a case insulinoma in dog managed with subcutaneous saline-diluted glucagon continuous glucose monitoring system (CGMS), which were glycemic control allowing long-term home treatment.